Status:
RECRUITING
Electromagnetic Therapy for Autism Spectrum Disorder
Lead Sponsor:
The University of Hong Kong
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
The investigators hypothesize that electromagnetic therapy (EMT) could produce greater improvement on Autism spectrum disorder (ASD) compared to the waitlist control. To test this hypothesis, a pilot ...
Eligibility Criteria
Inclusion
- aged 3-12 years;
- have had a principal diagnosis of ASD according to the diagnostic criteria for ASD in the DSM-5;
- The score of CARS is 30-37 (mild to moderate ASD) at entry; and
- his/her parents or legal guardian give a written informed consent that indicates the permission to participate in the study.
Exclusion
- Children suffer a significant comorbid congenital disease or brain injury, such as Down syndrome, mental retardation, and cerebral palsy;
- Children have been suffering uncontrolled epilepsy or seizure;
- Children have heart diseases;
- Children have participated in other investigational studies in previous 3 months;
- Children have pediatric massage or acupuncture in previous 2 months; or
- they have severe skin lesions or scar on the areas the treatment will be performed.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06085287
Start Date
March 1 2024
End Date
December 31 2025
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Services Centres, The School of Chinese Medicine, The University of Hong Kong
Hong Kong, Hong Kong